BlackRock Japan’s Jazz Pharmaceuticals JAZZ Stock Holding History

BlackRock Japan’s Portfolio JAZZ Stock Details JAZZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$8.55M	Buy	78,400 +1,186	+2%	+$132K	0.03%	578
2016 Q3	$9.38M	Buy	77,214 +909	+1%	+$123K	0.03%	544
2016 Q2	$10.8M	Sell	76,305 -85	-0.1%	-$12.5K	0.04%	482
2016 Q1	$9.97M	Sell	76,390 -429	-0.6%	-$53.4K	0.04%	502
2015 Q4	$10.8M	Buy	76,819 +2,304	+3%	+$319K	0.04%	485
2015 Q3	$9.9M	Buy	74,515 +3,803	+5%	+$655K	0.04%	482
2015 Q2	$12.4M	Buy	+70,712	New	+$12.7M	0.05%	431
2015 Q1	–	Sell	-72,026	Closed	-$11.8M	–	1331
2014 Q4	$11.8M	Buy	72,026 +71,764	+27,391%	+$11.9M	0.05%	451
2014 Q3	$42K	Buy	+262	New	+$40.3K	﹤0.01%	1074
2014 Q2	–	Sell	-25,003	Closed	-$3.47M	–	1340
2014 Q1	$3.47M	Buy	25,003 +22,027	+740%	+$3.32M	0.02%	653
2013 Q4	$377K	Buy	+2,976	New	+$308K	﹤0.01%	804

Other funds holding JAZZ

Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

CCM

Cadian Capital Management New York $1.32B AUM 4.19% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $139B AUM 29.06% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

BlackRock Japan's JAZZ Position: Q4 2016 in Review

BlackRock Japan increased its Jazz Pharmaceuticals (JAZZ) stake by 1.5% in Q4 2016, buying an estimated $132K and bringing the position to 78,400 shares worth $8.55M. The position accounts for 0.03% of the portfolio, ranked #578.

BlackRock Japan first reported a position in JAZZ in Q4 2013 and has held it in 11 quarters since. The position peaked at $12.4M in Q2 2015. 296 funds tracked by Wall St. Rank hold JAZZ as of Q4 2016.

BlackRock Japan held 78,400 shares of Jazz Pharmaceuticals worth $8.55M as of Q4 2016.
BlackRock Japan bought 1,186 Jazz Pharmaceuticals shares in Q4 2016, an estimated $132K.
Jazz Pharmaceuticals made up 0.03% of BlackRock Japan's portfolio in Q4 2016, its #578 holding.
BlackRock Japan first reported a position in Jazz Pharmaceuticals in Q4 2013 and has held it in 11 quarters since.
BlackRock Japan's Jazz Pharmaceuticals position peaked at $12.4M in Q2 2015.
296 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q4 2016.

Based on BlackRock Japan's 13F filing for Q4 2016, filed 10 Feb 2017.